FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4323348526> ?p ?o ?g. }

• W4323348526 endingPage "1180" @default.
• W4323348526 startingPage "1175" @default.
• W4323348526 abstract "Journal of Ultrasound in MedicineVolume 42, Issue 6 p. 1175-1180 Editorial Comparing Magnetic Resonance Imaging and Contrast-Enhanced Ultrasound (CEUS) for the Characterization of Nodules Found on Hepatocellular Carcinoma Surveillance CEUS is Our Clear Choice Kelly W. Burak MD, FRCPC, MSc (Epid), Corresponding Author Kelly W. Burak MD, FRCPC, MSc (Epid) [email protected] Calgary Liver Unit, Division of Gastroenterology and Hepatology, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada Division of Transplant Medicine, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada Division of Medical Oncology, Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada Address correspondence to Kelly W. Burak, Calgary Liver Unit, Division of Gastroenterology and Hepatology, Division of Transplant Medicine, Departments of Medicine and Oncology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada. E-mail: [email protected]Search for more papers by this authorLisa Douglas RN, NP, Lisa Douglas RN, NP Calgary Liver Unit, Division of Gastroenterology and Hepatology, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, CanadaSearch for more papers by this authorStephen E. Congly MD, FRCPC, MSc, Stephen E. Congly MD, FRCPC, MSc Calgary Liver Unit, Division of Gastroenterology and Hepatology, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada Division of Transplant Medicine, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, CanadaSearch for more papers by this author Kelly W. Burak MD, FRCPC, MSc (Epid), Corresponding Author Kelly W. Burak MD, FRCPC, MSc (Epid) [email protected] Calgary Liver Unit, Division of Gastroenterology and Hepatology, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada Division of Transplant Medicine, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada Division of Medical Oncology, Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada Address correspondence to Kelly W. Burak, Calgary Liver Unit, Division of Gastroenterology and Hepatology, Division of Transplant Medicine, Departments of Medicine and Oncology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada. E-mail: [email protected]Search for more papers by this authorLisa Douglas RN, NP, Lisa Douglas RN, NP Calgary Liver Unit, Division of Gastroenterology and Hepatology, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, CanadaSearch for more papers by this authorStephen E. Congly MD, FRCPC, MSc, Stephen E. Congly MD, FRCPC, MSc Calgary Liver Unit, Division of Gastroenterology and Hepatology, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada Division of Transplant Medicine, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, CanadaSearch for more papers by this author First published: 07 March 2023 https://doi.org/10.1002/jum.16200 Kelly W. Burak received honorarium from Canadian Multidisciplinary HCC meeting for organizing and speaking in 2021 and from CADTH for expert review of “Y90 for HCC” Health Technology Assessment in 2020. Lisa Doulgas has nothing to declare. Stephen E. Congly has research grants from Bristol-Myers Sqibb Canada, has received consulting fees from AstraZeneca and is on the Board of Directors for the Canadian Association for the Study of the Liver. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1Marrero JA, Kulik L, Sirlin CB, et al. Diagnosis, staging and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 2018; 68: 723– 750. 2 European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatology 2018; 69: 182– 236. 3Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020– 1022. 4Jo PC, Jang HJ, Burns PN, et al. Integration of CEUS into a multimodality approach to imaging of nodules in a cirrhotic liver: how I do it. Radiology 2017; 282: 317– 331. 5Aubé C, Oberti F, Lonjon J, et al. EASL and AASLD recommendations for the diagnosis of HCC to the test of daily practice. Liver Int 2017; 37: 1515– 1525. 6van der Pol CB, McInnes MDF, Salameh JP, et al. CT/MRI and CEUS LI-RADS major features association with hepatocellular carcinoma: individual patient data meta-analysis. Radiology 2022; 302: 326– 335. 7Hu J, Burrowes DP, Caine BA, et al. Nodules identified on surveillance ultrasound for HCC: CEUS or MRI as the initial test? J Ultrasound Med 2023; 42: 1181– 1190. 8Westwood M, Joore M, Grutters J, et al. Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis. Health Technol Assess 2013; 17: 1– 243. 9Tanaka H, Iijima H, Nouso K, et al. Cost-effectiveness analysis on the surveillance for hepatocellular carcinoma in liver cirrhosis patients using contrast-enhanced ultrasonography. Hepatol Res 2012; 42: 376– 384. 10Smajerova M, Petrasova H, Little J, et al. Contrast-enhanced ultrasonography in the evaluation of incidental focal liver lesions: a cost-effectiveness analysis. World J Gastroenterol 2016; 22: 8605– 8614. 11Streb JW, Tchelepi H, Malhi H, Deurdulian C, Grant EG. Retrospective analysis of contrast-enhanced ultrasonography effectiveness in reducing time to diagnosis and imaging-related expenditures at a single large United States county hospital. Ultrasound Q 2019; 35: 99– 102. 12 Centers for Medicare & Medicaid Services. CMS-1772-FC Hospital Outpatient Prospective Payment-Notice of Final Rulemaking with Comment Period (NFRM). https://www.cms.gov/medicaremedicare-fee-service-paymenthospitaloutpatientppshospital-outpatient-regulations-and-notices/cms-1772-fc. Accessed February 2, 2023. 13Terzi E, Iavarone M, Pompili M, et al. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter retrospective study of 1,006 nodules. J Hepatol 2018; 68: 485– 492. 14 Guideline Resource Unit Alberta Health Services. Hepatocellular Carcinoma. https://www.albertahealthservices.ca/assets/info/hp/cancer/if-hp-cancer-guide-gi007-hepatocellular-carcinoma.pdf. Accessed February 2, 2022. 15Bansal S, Gui J, Merrill C, et al. Contrast-enhanced US in local ablative therapy and secondary surveillance for hepatocellular carcinoma. Radiographics 2019; 39: 302– 1322. 16Bansal S, Lu F, Frehlich L, et al. A new proposal for secondary surveillance following potentially curative therapy of HCC: alternating MRI and CEUS. Abdom Radiol (NY) 2022; 47: 618– 629. Volume42, Issue6June 2023Pages 1175-1180 ReferencesRelatedInformation" @default.
• W4323348526 created "2023-03-08" @default.
• W4323348526 creator A5007856954 @default.
• W4323348526 creator A5043166071 @default.
• W4323348526 creator A5069062571 @default.
• W4323348526 date "2023-03-07" @default.
• W4323348526 modified "2023-10-02" @default.
• W4323348526 title "Comparing Magnetic Resonance Imaging and Contrast‐Enhanced Ultrasound (<scp>CEUS</scp>) for the Characterization of Nodules Found on Hepatocellular Carcinoma Surveillance" @default.
• W4323348526 cites W1855475699 @default.
• W4323348526 cites W2146653196 @default.
• W4323348526 cites W2163403599 @default.
• W4323348526 cites W2277004004 @default.
• W4323348526 cites W2530087477 @default.
• W4323348526 cites W2579018382 @default.
• W4323348526 cites W2603225292 @default.
• W4323348526 cites W2768049771 @default.
• W4323348526 cites W2796067155 @default.
• W4323348526 cites W2889303954 @default.
• W4323348526 cites W2966644912 @default.
• W4323348526 cites W3212257223 @default.
• W4323348526 cites W3214393651 @default.
• W4323348526 cites W4321372831 @default.
• W4323348526 doi "https://doi.org/10.1002/jum.16200" @default.
• W4323348526 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36880711" @default.
• W4323348526 hasPublicationYear "2023" @default.
• W4323348526 type Work @default.
• W4323348526 citedByCount "1" @default.
• W4323348526 countsByYear W43233485262023 @default.
• W4323348526 crossrefType "journal-article" @default.
• W4323348526 hasAuthorship W4323348526A5007856954 @default.
• W4323348526 hasAuthorship W4323348526A5043166071 @default.
• W4323348526 hasAuthorship W4323348526A5069062571 @default.
• W4323348526 hasConcept C120665830 @default.
• W4323348526 hasConcept C121332964 @default.
• W4323348526 hasConcept C126322002 @default.
• W4323348526 hasConcept C126838900 @default.
• W4323348526 hasConcept C142724271 @default.
• W4323348526 hasConcept C143409427 @default.
• W4323348526 hasConcept C143753070 @default.
• W4323348526 hasConcept C2776502983 @default.
• W4323348526 hasConcept C2777546739 @default.
• W4323348526 hasConcept C2778019345 @default.
• W4323348526 hasConcept C2779585989 @default.
• W4323348526 hasConcept C529618451 @default.
• W4323348526 hasConcept C71924100 @default.
• W4323348526 hasConceptScore W4323348526C120665830 @default.
• W4323348526 hasConceptScore W4323348526C121332964 @default.
• W4323348526 hasConceptScore W4323348526C126322002 @default.
• W4323348526 hasConceptScore W4323348526C126838900 @default.
• W4323348526 hasConceptScore W4323348526C142724271 @default.
• W4323348526 hasConceptScore W4323348526C143409427 @default.
• W4323348526 hasConceptScore W4323348526C143753070 @default.
• W4323348526 hasConceptScore W4323348526C2776502983 @default.
• W4323348526 hasConceptScore W4323348526C2777546739 @default.
• W4323348526 hasConceptScore W4323348526C2778019345 @default.
• W4323348526 hasConceptScore W4323348526C2779585989 @default.
• W4323348526 hasConceptScore W4323348526C529618451 @default.
• W4323348526 hasConceptScore W4323348526C71924100 @default.
• W4323348526 hasIssue "6" @default.
• W4323348526 hasLocation W43233485261 @default.
• W4323348526 hasLocation W43233485262 @default.
• W4323348526 hasOpenAccess W4323348526 @default.
• W4323348526 hasPrimaryLocation W43233485261 @default.
• W4323348526 hasRelatedWork W2008541301 @default.
• W4323348526 hasRelatedWork W2045203490 @default.
• W4323348526 hasRelatedWork W2276392809 @default.
• W4323348526 hasRelatedWork W2363572072 @default.
• W4323348526 hasRelatedWork W2526999821 @default.
• W4323348526 hasRelatedWork W2612902786 @default.
• W4323348526 hasRelatedWork W2979003513 @default.
• W4323348526 hasRelatedWork W3175806596 @default.
• W4323348526 hasRelatedWork W4206520822 @default.
• W4323348526 hasRelatedWork W2193881183 @default.
• W4323348526 hasVolume "42" @default.
• W4323348526 isParatext "false" @default.
• W4323348526 isRetracted "false" @default.
• W4323348526 workType "article" @default.